Gelblum DY - Search Results

1

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.

Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group. Tsai CJ, et al. Among authors: gelblum dy. Lancet. 2024 Jan 13;403(10422):171-182. doi: 10.1016/S0140-6736(23)01857-3. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104577 Clinical Trial.

2

Gd HP-DO3A--experimental evaluation in brain and renal MR.

Runge VM, Gelblum DY, Jacobson S. Runge VM, et al. Among authors: gelblum dy. Magn Reson Imaging. 1991;9(1):79-87. doi: 10.1016/0730-725x(91)90100-z. Magn Reson Imaging. 1991. PMID: 2056855

3

Future directions in magnetic resonance contrast media.

Runge VM, Gelblum DY. Runge VM, et al. Among authors: gelblum dy. Top Magn Reson Imaging. 1991 Mar;3(2):85-97. Top Magn Reson Imaging. 1991. PMID: 2025435 Review.

4

3-D imaging of the CNS.

Runge VM, Gelblum DY, Wood ML. Runge VM, et al. Among authors: gelblum dy. Neuroradiology. 1990;32(5):356-66. doi: 10.1007/BF00588469. Neuroradiology. 1990. PMID: 2259430

5

The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.

Runge VM, Gelblum DY. Runge VM, et al. Among authors: gelblum dy. Magn Reson Q. 1990 Apr;6(2):85-107. Magn Reson Q. 1990. PMID: 2202425 Review. No abstract available.

6

Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics.

Goldstein EJ, Burnett KR, Hansell JR, Casaia J, Dizon J, Farrar B, Gelblum D, Wolf GL. Goldstein EJ, et al. Physiol Chem Phys Med NMR. 1984;16(2):97-104. Physiol Chem Phys Med NMR. 1984. PMID: 6095342

7

Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.

Runge VM, Carollo BR, Wolf CR, Nelson KL, Gelblum DY. Runge VM, et al. Among authors: gelblum dy. Radiographics. 1989 Sep;9(5):929-58. doi: 10.1148/radiographics.9.5.2678298. Radiographics. 1989. PMID: 2678298 Review.

8

Improvements in MR angiography using phase-corrected data sets.

Chenevert TL, Fechner KP, Gelblum DY. Chenevert TL, et al. Among authors: gelblum dy. Magn Reson Med. 1989 Apr;10(1):38-49. doi: 10.1002/mrm.1910100104. Magn Reson Med. 1989. PMID: 2666811 Free article.

9

Gd-HP-DO3A in clinical MR imaging of the brain.

Runge VM, Gelblum DY, Pacetti ML, Carolan F, Heard G. Runge VM, et al. Among authors: gelblum dy. Radiology. 1990 Nov;177(2):393-400. doi: 10.1148/radiology.177.2.2217775. Radiology. 1990. PMID: 2217775 Clinical Trial.

10

Dysmyelinogenesis in animal model of GM1 gangliosidosis.

Kaye EM, Alroy J, Raghavan SS, Schwarting GA, Adelman LS, Runge V, Gelblum D, Thalhammer JG, Zuniga G. Kaye EM, et al. Pediatr Neurol. 1992 Jul-Aug;8(4):255-61. doi: 10.1016/0887-8994(92)90361-2. Pediatr Neurol. 1992. PMID: 1388413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters